Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study

Journal of Pathology

Volumn 223, Issue 4, 2011, Pages 511-518

  Wadsworth, Jonathan D F ^a   Dalmau Mena, Inmaculada ^a   Joiner, Susan ^a   Linehan, Jacqueline M ^a   O'Malley, Catherine ^a   Powell, Caroline ^a   Brandner, Sebastian ^a   Asante, Emmanuel A ^a   Ironside, James W ^b   Hilton, David A ^c   Collinge, John ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

bovine spongiform encephalopathy; prion disease; prion strain; prion transmission; variant Creutzfeldt Jakob disease

Indexed keywords

FORMALDEHYDE; GLYCOSYLATED PROTEIN; PARAFFIN; PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APPENDIX; ARTICLE; BIOASSAY; BRAIN; CASE REPORT; DISEASE TRANSMISSION; HUMAN; HUMAN TISSUE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULOENDOTHELIAL SYSTEM; SPLEEN; TISSUE FIXATION; VARIANT CREUTZFELDT JAKOB DISEASE;

ANIMALS; APPENDIX; BIOLOGICAL ASSAY; BRAIN; CREUTZFELDT-JAKOB SYNDROME; HUMANS; MICE; MICE, TRANSGENIC; PRIONS; PRPSC PROTEINS; RETROSPECTIVE STUDIES; TISSUE FIXATION;

EID: 79551700870     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2821     Document Type: Article

References (70)

1. Will RG, Ironside JW, Zeidler M, et al., A new variant of Creut (Pubitemid 26102546)
2. Collinge J, Sidle KC, Meads J, et al., Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383: 685-690. (Pubitemid 26360638)
3. Hill AF, Desbruslais M, Joiner S, et al., The same prion strain causes vCJD and BSE. Nature 1997; 389: 448-450, 526. (Pubitemid 27435311)
4. Bruce ME, Will RG, Ironside JW, et al., Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498-501. (Pubitemid 27435325)
5. Asante EA, Linehan JM, Desbruslais M, et al., BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002; 21: 6358-6366. (Pubitemid 35448414)
6. Collinge J,. Variant Creutzfeldt-Jakob disease. Lancet 1999; 354: 317-323. (Pubitemid 29348751)
7. Collinge J,. Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 2005; 76: 906-919. (Pubitemid 40909547)
8. Wadsworth JD, Collinge J,. Update on human prion disease. Biochim Biophys Acta 2007; 1772: 598-609. (Pubitemid 46887654)
9. Adkin A, Webster V, Arnold ME, et al., Estimating the impact on the food chain of changing bovine spongiform encephalopathy (BSE) control measures: the BSE control model. Prev Vet Med 2010; 93: 170-182.
10. Ghani AC, Donnelly CA, Ferguson NM, et al., Updated projections of future vCJD deaths in the UK. BMC Infect Dis 2003; 3: 4.
11. Hill AF, Joiner S, Linehan J, et al., Species barrier independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A 2000; 97: 10248-10253.
12. Hill AF, Collinge J,. Subclinical prion infection in humans and animals. Br Med Bull 2003; 66: 161-170. (Pubitemid 37173500)
13. Race R, Raines A, Raymond GJ, et al., Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J Virol 2001; 75: 10106-10112. (Pubitemid 32948040)
14. Thackray AM, Klein MA, Aguzzi A, et al., Chronic subclinical prion disease induced by low-dose inoculum. J Virol 2002; 76: 2510-2517. (Pubitemid 34150719)
15. Georgsson G, Adolfsdottir JA, Palsdottir A, et al., High incidence of subclinical infection of lymphoid tissues in scrapie-affected sheep flocks. Arch Virol 2008; 153: 637-644.
16. Clarke P, Ghani AC,. Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility. J R Soc Interface 2005; 2: 19-31.
17. SEAC. SEAC 100/6. Resolving the discrepancy in current estimates. Spongiform Encephalopathy Advisory Committee; [Accessed 13 September 2010]: Available from:.
18. SEAC. SEAC 100/2. Combining evidence from tissue surveys to estimate prevalence of subclinical vCJD. Spongiform Encephalopathy Advisory Committee; [Accessed 13 September 2010]: Available from:.
19. SEAC. SEAC 104/2. Estimating the prevalence of subclinical vCJD. Spongiform Encephalopathy Advisory Committee; [Accessed 13 September 2010]: Available from:.
20. Collinge J, Whitfield J, McKintosh E, et al., Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet 2006; 367: 2068-2074. (Pubitemid 43949290)
21. Collinge J, Whitfield J, McKintosh E, et al., A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Philos Trans R Soc London Ser B Biol Sci 2008; 363: 3725-3739.
22. Stephenson DA, Chiotti K, Ebeling C, et al., Quantitative trait loci affecting prion incubation time in mice. Genomics 2000; 69: 47-53.
23. Lloyd S, Onwuazor ON, Beck J, et al., Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A 2001; 98: 6279-6283. (Pubitemid 32488230)
24. Lloyd S, Uphill JB, Targonski PV, et al., Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice. Neurogenetics 2002; 4: 77-81. (Pubitemid 36019501)
25. Lloyd SE, Maytham EG, Grizenkova J, et al., A Copine family member, Cpne8, is a candidate quantitative trait gene for prion disease incubation time in mouse. Neurogenetics 2009; 11: 185-191.
26. Mead S, Poulter M, Uphill J, et al., Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol 2009; 8: 57-66.
27. Lloyd SE, Maytham EG, Pota H, et al., HECTD2 is associated with susceptibility to mouse and human prion disease. PLoS Genet 2009; 5: e1000383.
28. Llewelyn CA, Hewitt PE, Knight RS, et al., Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-421. (Pubitemid 38210057)
29. Peden AH, Head MW, Ritchie DL, et al., Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527-529. (Pubitemid 39070413)
30. Wroe SJ, Pal S, Siddique D, et al., Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006; 368: 2061-2067. (Pubitemid 44855106)
31. Peden A, McCardle L, Head MW, et al., Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 2010; 16: 296-304.
32. Armitage WJ, Tullo AB, Ironside JW,. Risk of Creutzfeldt-Jakob disease transmission by ocular surgery and tissue transplantation. Eye 2009; 10: 1926-1930.
33. Hill AF, Butterworth RJ, Joiner S, et al., Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353: 183-189. (Pubitemid 29088029)
34. Wadsworth JD, Joiner S, Hill AF, et al., Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay. Lancet 2001; 358: 171-180. (Pubitemid 32718539)
35. Hilton DA, Sutak J, Smith ME, et al., Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 2004; 57: 300-302. (Pubitemid 38338845)
36. Head MW, Ritchie D, Smith N, et al., Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 2004; 164: 143-153. (Pubitemid 38364599)
37. Joiner S, Linehan J, Brandner S, et al., High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease. Gut 2005; 54: 1506-1508. (Pubitemid 41375217)
38. Brandner S, Whitfield J, Boone K, et al., Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease. Philos Trans R Soc London Ser B Biol Sci 2008; 363: 3755-3763.
39. Wadsworth JD, Joiner S, Linehan JM, et al., Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc Natl Acad Sci U S A 2008; 105: 3885-3890. (Pubitemid 351723494)
40. Hilton DA, Fathers E, Edwards P, et al., Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998; 352: 703-704.
41. Hilton DA, Ghani AC, Conyers L, et al., Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203: 733-739. (Pubitemid 38961558)
42. Gambetti P, Dong Z, Yuan J, et al., A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 2008; 63: 697-708. (Pubitemid 351945529)
43. Zou WQ, Puoti G, Xiao X, et al., Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 2010; 68: 162-172.
44. Jansen C, Head MW, Van Gool WA, et al., The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype. J Neurol Neurosurg Psychiatry 2010; 81: 1052-1055.
45. Head MW, Knight R, Zeidler M, et al., A case of protease sensitive prionopathy in a patient in the United Kingdom. Neuropathol Appl Neurobiol 2009; 35: 628-632.
46. Frosh A, Smith LC, Jackson CJ, et al., Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet 2004; 364: 1260-1262. (Pubitemid 39311347)
47. Clewley JP, Kelly CM, Andrews N, et al., Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. Br Med J 2009; 338: b1442.
48. Joiner S, Linehan J, Brandner S, et al., Irregular presence of abnormal prion protein in appendix in variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2002; 73: 597-598. (Pubitemid 35246821)
49. de Marco MF, Linehan J, Gill ON, et al., Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain. J Pathol 2010; DOI:10.1002/path.2767.
50. Ironside JW, Bishop MT, Connolly K, et al., Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. Br Med J 2006; 2006: 1164-1165.
51. Wadsworth JD, Asante EA, Desbruslais M, et al., Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 2004; 306: 1793-1796. (Pubitemid 39601400)
52. Collinge J, Clarke A,. A general model of prion strains and their pathogenicity. Science 2007; 318: 930-936. (Pubitemid 350098981)
53. Collinge J, Palmer MS, Dryden AJ,. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991; 337: 1441-1442.
54. Palmer MS, Dryden AJ, Hughes JT, et al., Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352: 340-342. (Pubitemid 21912354)
55. Hill AF, Joiner S, Wadsworth JD, et al., Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 2003; 126: 1333-1346. (Pubitemid 36644379)
56. Kaski D, Mead S, Hyare H, et al., Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 2009; 374: 2128.
57. Wadsworth JD, Joiner S, Fox K, et al., Prion infectivity in variant Creutzfeldt-Jakob disease rectum. Gut 2007; 56: 90-94. (Pubitemid 46044893)
58. Asante E, Linehan J, Gowland I, et al., Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci U S A 2006; 103: 10759-10764. (Pubitemid 44078049)
59. Wadsworth JD, Powell C, Beck J, et al., Molecular diagnosis of human prion disease. Methods Mol Biol 2008; 459: 197-227.
60. Kascsak RJ, Rubenstein R, Merz PA, et al., Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 1987; 61: 3688-3693. (Pubitemid 18011463)
61. Hill AF, Joiner S, Beck J, et al., Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain 2006; 129: 676-685. (Pubitemid 43278229)
62. Sc molecules with different conformations. Nature Med 1998; 4: 1157-1165. (Pubitemid 28468829)
63. Brown P, Gibbs CJ Jr, Gajdusek DC, et al., Transmission of Creutzfeldt-Jakob disease from formalin-fixed, paraffin-embedded human brain tissue. N Engl J Med 1986; 315: 1614-1615. (Pubitemid 17055404)
64. Brown P, Gibbs CJ Jr, Rodgers Johnson P, et al., Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-529. (Pubitemid 24153834)
65. Brown P, Rohwer RG, Green EM, et al., Effect of chemicals, heat, and histopathologic processing on high-infectivity hamster-adapted scrapie virus. J Infect Dis 1982; 145: 683-687. (Pubitemid 12116456)
66. Brown P, Liberski PP, Wolff A, et al., Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 °C: practical and theoretical implications. J Infect Dis 1990; 161: 467-472. (Pubitemid 20107947)
67. Di Bari MA, Chianini F, Vaccari G, et al., The bank vole (Myodes glareolus) as a sensitive bioassay for sheep scrapie. J Gen Virol 2008; 89: 2975-2985.
68. Ritchie DL, Boyle A, McConnell I, et al., Transmissions of variant Creutzfeldt-Jakob disease from brain and lymphoreticular tissue show uniform and conserved BSE-related phenotypic properties on primary and secondary passage in wild-type mice. J Gen Virol 2009; 90: 3075-3082.
69. Li J, Browning S, Mahal SP, et al., Darwinian evolution of prions in cell culture. Science 2010; 327: 869-872.
70. Bishop MT, Ritchie DL, Will RG, et al., No major change in vCJD agent strain after secondary transmission via blood transfusion. PLoS ONE 2008; 3: e2878.